Viewing StudyNCT01643499



Ignite Creation Date: 2024-05-06 @ 12:44 AM
Last Modification Date: 2024-10-26 @ 10:54 AM
Study NCT ID: NCT01643499
Status: COMPLETED
Last Update Posted: 2020-05-08
First Post: 2012-07-16

Brief Title: Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Sponsor: University of Chicago
Organization: University of Chicago

Conditions & Keywords Data

Conditions:
Name
Acinar Cell Adenocarcinoma of the Pancreas
Adenocarcinoma of the Gallbladder
Adenocarcinoma of Unknown Primary
Adult Primary Cholangiocellular Carcinoma
Advanced Adult Primary Liver Cancer
Cholangiocarcinoma of the Extrahepatic Bile Duct
Cholangiocarcinoma of the Gallbladder
Diffuse Adenocarcinoma of the Stomach
Duct Cell Adenocarcinoma of the Pancreas
Intestinal Adenocarcinoma of the Stomach
Localized Unresectable Adult Primary Liver Cancer
Metastatic Carcinoma of Unknown Primary
Metastatic Extrahepatic Bile Duct Cancer
Mixed Adenocarcinoma of the Stomach
Mucinous Adenocarcinoma of the Colon
Mucinous Adenocarcinoma of the Rectum
Newly Diagnosed Carcinoma of Unknown Primary
Signet Ring Adenocarcinoma of the Colon
Signet Ring Adenocarcinoma of the Rectum
Stage III Pancreatic Cancer
Stage IIIA Colon Cancer
Stage IIIA Gallbladder Cancer
Stage IIIA Gastric Cancer
Stage IIIA Rectal Cancer
Stage IIIB Colon Cancer
Stage IIIB Gallbladder Cancer
Stage IIIB Gastric Cancer
Stage IIIB Rectal Cancer
Stage IIIC Colon Cancer
Stage IIIC Gastric Cancer
Stage IIIC Rectal Cancer
Stage IV Gastric Cancer
Stage IV Pancreatic Cancer
Stage IVA Colon Cancer
Stage IVA Gallbladder Cancer
Stage IVA Rectal Cancer
Stage IVB Colon Cancer
Stage IVB Gallbladder Cancer
Stage IVB Rectal Cancer
Unresectable Extrahepatic Bile Duct Cancer
Keywords: